Evidence map›Paper›PMID 36359247›Full record

ArticleBiomedicines2022

The Executive Functioning Paradox in Substance Use Disorders.

Louise Jakubiec, Valentine Chirokoff, Majd Abdallah, Ernesto Sanz-Arigita, Maud Dupuy, Joel Swendsen, Sylvie Berthoz, Fabien Gierski, Sarah Guionnet, David Misdrahi and 3 more

Open access · goldAbstract read
In one paragraph

Article in Biomedicines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Louise JakubiecCentre National de la Recherche Scientifique (CNRS), Institut de Neurosciences Cognitives et Intégratives d'Aquitaine (INCIA), University of Bordeaux, UMR 5287, 33000 Bordeaux, France.
Valentine ChirokoffCNRS, Ecole Pratique des Hautes Etudes, INCIA, University of Bordeaux, UMR 5287, 33000 Bordeaux, France.
Majd AbdallahParietal Team, INRIA Saclay Ile-de-France, 91120 Palaiseau, France.ORCID 0000-0002-8371-1793
Ernesto Sanz-ArigitaCentre National de la Recherche Scientifique (CNRS), Institut de Neurosciences Cognitives et Intégratives d'Aquitaine (INCIA), University of Bordeaux, UMR 5287, 33000 Bordeaux, France.
Maud DupuyCentre National de la Recherche Scientifique (CNRS), Institut de Neurosciences Cognitives et Intégratives d'Aquitaine (INCIA), University of Bordeaux, UMR 5287, 33000 Bordeaux, France.ORCID 0000-0002-0725-042X
Joel SwendsenCNRS, Ecole Pratique des Hautes Etudes, INCIA, University of Bordeaux, UMR 5287, 33000 Bordeaux, France.
Sylvie BerthozCentre National de la Recherche Scientifique (CNRS), Institut de Neurosciences Cognitives et Intégratives d'Aquitaine (INCIA), University of Bordeaux, UMR 5287, 33000 Bordeaux, France.ORCID 0000-0002-6862-2362
Fabien GierskiLaboratoire Cognition, Santé et Société, University of Reims Champagne Ardenne, 51571 Reims, France.ORCID 0000-0001-9168-2024
Sarah GuionnetCentre National de la Recherche Scientifique (CNRS), Institut de Neurosciences Cognitives et Intégratives d'Aquitaine (INCIA), University of Bordeaux, UMR 5287, 33000 Bordeaux, France.
David MisdrahiCentre National de la Recherche Scientifique (CNRS), Institut de Neurosciences Cognitives et Intégratives d'Aquitaine (INCIA), University of Bordeaux, UMR 5287, 33000 Bordeaux, France.ORCID 0000-0003-1146-3206
Fuschia SerreCNRS, SANPSY, University of Bordeaux, UMR 6033, 33000 Bordeaux, France.ORCID 0000-0002-0228-3572
Marc AuriacombeDepartment of Addictology, CH Charles Perrens, 33000 Bordeaux, France.ORCID 0000-0002-8938-8683
Melina FatseasCentre National de la Recherche Scientifique (CNRS), Institut de Neurosciences Cognitives et Intégratives d'Aquitaine (INCIA), University of Bordeaux, UMR 5287, 33000 Bordeaux, France.
Centre National de la Recherche Scientifique · FRInstitut national de recherche en sciences et technologies du numérique · FRUniversité de Reims Champagne-Ardenne · FR

Funding

Agence Nationale de la Recherche ANR-12-BSH2-0012
6 · The paper itself

Abstract

Deficits in neurocognitive functioning are trait-like vulnerabilities that have been widely studied in persons with substance use disorders (SUD), but their role in the craving-use association and relapse vulnerability remains poorly understood. The main objectives of this study were to examine whether executive capacities moderate the magnitude of the craving-substance use relationship, and if this influence is correlated with the functional connectivity of cerebral networks, combining rsfMRI examinations and ecological momentary assessment (EMA). Eighty-six patients beginning outpatient treatment for alcohol, tobacco or cannabis addiction and 40 healthy controls completed neuropsychological tests followed by EMA to collect real-time data on craving. Fifty-four patients and 30 healthy controls also completed a resting-state fMRI before the EMA. Among the patients with SUD, better verbal fluency and resistance to interference capacities were associated with a greater propensity to use substances when the individual was experiencing craving. Preliminary rsfMRI results identified specific networks that interacted with executive performance capacities to influence the magnitude of the craving-use association. Individuals with better executive functioning may be more prone to relapse after craving episodes. Specifically, better resistance to interference and cognitive flexibility skills may reduce attention to distracting stimuli, leading to a greater awareness of craving and susceptibility to use substances.

Indexed as

cravingecological momentary assessmentexecutive functionsrelapseresting statersfMRIsubstance use disorders

Identifiers

PMID36359247
PMCPMC9687962
OpenAlexW4307943442

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.